PUMA BIOTECHNOLOGY INC
€6.290
EUR
Last updated on --.
24h volume154.31K
24h highest6.4036 EUR
24h lowest6.2350 EUR
24h Price movement+0.62%
PBYI recent prices
24 Hours
+0.62%+€0.0387
30 days
-2.79%-€0.1806
60 days
+19.58%+€1.032
90 days
+28.60%+€1.401
Key data
Previous close6.2522 EUR
Market cap305.98M EUR
Volume154.31K
P/E ratio14.590000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.41280 EUR
Net income (FY)20.97M EUR
Revenue (FY)195.37M EUR
Last report dateMay 7, 2026
About PUMA BIOTECHNOLOGY INC
HeadquartersLOS ANGELES
Employees (FY)179.00
Revenue per employee (FY)1.09M EUR
Net income per employee (FY)117.15K EUR
Listed onNasdaq
PBYI conversion tables
 |  |
|---|---|
| 0.5 PBYI | 3.145 EUR |
| 1 PBYI | 6.290 EUR |
| 5 PBYI | 31.45 EUR |
| 10 PBYI | 62.9 EUR |
| |
|---|---|
| 0.5 EUR | 0.07948 PBYI |
| 1 EUR | 0.15896 PBYI |
| 5 EUR | 0.7948 PBYI |
| 10 EUR | 1.589 PBYI |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PBYI is trading at €6.290, +0.62% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PBYI stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PBYI is currently trading at €6.290, +0.62% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PBYI price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PBYI's P/E ratio is currently 14.590000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PBYI; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PBYI's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
PUMA BIOTECHNOLOGY INC's market cap is currently 305.98M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume154.31K
24h highest6.4036 EUR
24h lowest6.2350 EUR
24h Price movement+0.62%
Start trade with PBYI Perpetual
Sign up to trade